B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Dovitinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Dovitinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

su
163 shared targets
nintedanib
151 shared targets
kw
165 shared targets
pha
117 shared targets
fedratinib
158 shared targets
tozasertib
131 shared targets
midostaurin
131 shared targets
lestaurtinib
174 shared targets
r
143 shared targets
tae
149 shared targets
Loading evidence profile...

This evidence profile for Dovitinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.